Option 2 of the policy includes cover for the out-patient investigation and treatment of cancer which arises after the start of the policy. This includes radiotherapy or chemotherapy, alone or in combination. In addition to the traditional cancer treatment covered by the plan, members will also have up to 12 months cover, subject to the policy terms and conditions, for licensed chemotherapy drug treatments (such as Herceptin and Avastin) which may be needed for a prolonged period of time.

If the Cancer Upgrade option is chosen, members will instead have up to 36 months cover.